openPR Logo
Press release

Nuclear Imaging Devices Market to Reach USD 6.2 Billion by 2034

11-12-2025 12:16 PM CET | Business, Economy, Finances, Banking & Insurance

Press release from: Exactitude Consultancy

Nuclear Imaging Devices Market to Reach USD 6.2 Billion by 2034

Nuclear Imaging Devices Market to Reach USD 6.2 Billion by 2034

Pune, India, November 2025 - According to the latest report by Exactitude Consultancy, the Global Nuclear Imaging Devices Market is valued at USD 4.1 billion in 2024 and is projected to reach USD 6.2 billion by 2034, growing at a CAGR of 4.2% from 2025 to 2034. The increasing use of molecular imaging for oncology and cardiology diagnostics, along with rapid advancements in PET, SPECT, and hybrid imaging technologies, continues to fuel the market's growth worldwide.

Download Full PDF Sample Copy of Market Report @
https://exactitudeconsultancy.com/request-sample/49316

Key Takeaways
• Market Size (2024): USD 4.1 Billion
• Forecast (2034): USD 6.2 Billion
• CAGR (2025-2034): 4.2%
• Major Growth Drivers: Rising incidence of cancer and cardiovascular diseases, growing use of PET/CT and SPECT/CT systems, and integration of artificial intelligence (AI) for image analysis.
• Leading Companies: Siemens Healthineers AG, GE HealthCare Technologies Inc., Canon Medical Systems Corporation, Philips Healthcare, Mediso Medical Imaging Systems, Neusoft Medical Systems, and Positron Corporation.

Market Story
The Nuclear Imaging Devices Market plays a pivotal role in modern diagnostic medicine by providing precise functional and anatomical insights at the molecular level. Nuclear imaging technologies-such as Positron Emission Tomography (PET) and Single Photon Emission Computed Tomography (SPECT)-enable early detection and monitoring of cancers, heart diseases, neurological disorders, and metabolic conditions.

Over the past decade, the market has witnessed a paradigm shift toward hybrid imaging systems (PET/CT, PET/MRI, and SPECT/CT), which combine anatomical precision with metabolic data, enhancing diagnostic accuracy. The integration of AI and machine learning algorithms has further improved image reconstruction, noise reduction, and predictive analytics in radiology workflows.
Growing investments in radiopharmaceutical R&D, coupled with government funding for advanced imaging infrastructure, continue to strengthen global adoption. Emerging markets are now rapidly modernizing their healthcare systems to expand nuclear imaging capacity and reduce diagnostic delays.

Explore Full Report here:
https://exactitudeconsultancy.com/reports/49316/nuclear-imaging-devices-market

Market Segmentation
By Product Type:
• PET (Positron Emission Tomography) Systems
• SPECT (Single Photon Emission Computed Tomography) Systems
• Hybrid Imaging Systems (PET/CT, PET/MRI, SPECT/CT)
• Planar Scintigraphy Systems

By Application:
• Oncology
• Cardiology
• Neurology
• Others (Orthopedic, Gastrointestinal, Endocrinology)

By End-User:
• Hospitals
• Diagnostic Imaging Centers
• Research Institutes
• Specialty Clinics

By Region:
• North America
• Europe
• Asia Pacific
• Latin America
• Middle East & Africa

Recent Developments
• 2025: Siemens Healthineers launched its Biograph Vision Quadra PET/CT system, enhancing field-of-view and time-of-flight imaging for oncology applications.
• 2024: GE HealthCare introduced its AI-assisted molecular imaging platform for precision oncology and cardiology diagnostics.
• 2024: Canon Medical Systems unveiled a next-generation SPECT/CT system with improved photon sensitivity and faster reconstruction.
• 2023: Philips Healthcare expanded its digital PET portfolio, integrating cloud-based image analytics for early-stage disease detection.

Get Your Exclusive Offer with up to 10% Discount :
https://exactitudeconsultancy.com/checkout/?currency=USD&type=single_user_license&report_id=49316

Expert Insight
"The combination of AI, molecular imaging, and hybrid modalities is redefining how clinicians diagnose and monitor diseases," said Irfan Tamboli, Business Development Executive at Exactitude Consultancy.
"Nuclear imaging devices are no longer just diagnostic tools-they are becoming the foundation of precision medicine and data-driven clinical decisions."

Regional Outlook
• North America leads the global market with more than 40% share, supported by early technology adoption, reimbursement availability, and strong research networks.
• Europe follows with increased investment in hybrid imaging and radiopharmaceutical production facilities.
• Asia Pacific is expected to grow at the fastest rate (CAGR above 5.5%), driven by healthcare modernization, government funding, and expanding diagnostic capacity in India, China, and Japan.
• Latin America & Middle East are emerging markets with improving nuclear medicine infrastructure and growing training initiatives.

Conclusion
The Nuclear Imaging Devices Market is transitioning toward high-precision, AI-assisted molecular imaging that enables early and accurate diagnosis. With increasing global healthcare expenditure and the expansion of hybrid imaging facilities, the next decade will witness widespread adoption of digital and cloud-integrated nuclear imaging technologies that elevate diagnostic and therapeutic outcomes.

This report is also available in the following languages : Japanese (核イメージング装置), Korean (핵의학 영상 장치), Chinese (核成像设备), French (Dispositifs d'imagerie nucléaire), German (Nuklearmedizinische Bildgebungsgeräte), and Italian (Dispositivi di imaging nucleare), etc.

Request for a sample of this research report at (Use Corporate Mail ID for Quick Response) @
https://exactitudeconsultancy.com/request-sample/49316

Our More Reports:

Pain Patch Market
https://exactitudeconsultancy.com/reports/49872/pain-patch-market

Antibiotic Resistance Market
https://exactitudeconsultancy.com/reports/49874/antibiotic-resistance-market

Cardiac Biomarkers Market
https://exactitudeconsultancy.com/reports/49877/cardiac-biomarkers-market

Medical Drones Market
https://exactitudeconsultancy.com/reports/65801/medical-drones-market

About Us
Exactitude Consultancy is a market research & consulting services firm which helps its client to address their most pressing strategic and business challenges. Our market research helps clients to address critical business challenges and also helps make optimized business decisions with our fact-based research insights, market intelligence, and accurate data.
https://bulletin.exactitudeconsultancy.com/

https://www.thehealthanalytics.com/

https://www.analytica.global/

https://www.marketintelligencedata.com/

https://www.marketinsightsreports.com/

https://exactitudeconsultancy.com/

Connect Us:
Irfan Tamboli
PHONE NUMBER +1 (704) 266-3234
EMAIL ADDRESS: sales@exactitudeconsultancy.com

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Nuclear Imaging Devices Market to Reach USD 6.2 Billion by 2034 here

News-ID: 4266522 • Views:

More Releases from Exactitude Consultancy

Alzheimer's Disease (In-68) Market Advances as Early Diagnosis, PET Imaging & Disease-Modifying Therapies Gain Momentum
Alzheimer's Disease (In-68) Market Advances as Early Diagnosis, PET Imaging & Di …
Alzheimer's disease (AD) is one of the fastest-growing neurological disorders worldwide, and demand for advanced diagnostic tracers-especially 68Ga-based (In-68) PET imaging agents-is rising sharply. With early detection becoming central to effective disease management, this market is seeing significant innovation in imaging technologies, biomarker development, and targeted therapeutics. This press release covers key trends, diagnostic advancements, and the evolving landscape reshaping AD care. Download Full PDF Sample Copy of Market Report @https://exactitudeconsultancy.com/request-sample/73641 Market
Clostridioides Difficile Infections (CDI) Market Expands as Diagnostic Advancements, Novel Antibiotics & Microbiome Therapies Transform Clinical Management
Clostridioides Difficile Infections (CDI) Market Expands as Diagnostic Advanceme …
Clostridioides difficile infection (CDI) remains one of the most common and severe healthcare-associated infections worldwide. As hospitals intensify infection-control practices and researchers pursue new antibiotics, monoclonal antibodies, and microbiome therapies, the CDI clinical market is undergoing major transformation. This press release highlights key trends, diagnostic innovations, market structure, and the evolving therapeutic landscape improving CDI outcomes across the globe. Download Full PDF Sample Copy of Market Report @https://exactitudeconsultancy.com/request-sample/73639 Market Overview The Global CDI
Sleep Apnea Clinical Market Grows Rapidly as Rising Prevalence, Home Sleep Testing & Advanced Therapeutics Transform Global Care
Sleep Apnea Clinical Market Grows Rapidly as Rising Prevalence, Home Sleep Testi …
Sleep apnea-one of the most underdiagnosed yet widespread sleep disorders-has become a global clinical priority. As awareness increases and diagnostic technologies evolve, millions are being screened earlier for obstructive, central, and complex sleep apnea. This press release highlights how advancements in home sleep testing, PAP therapy innovation, wearable monitoring, and AI-driven diagnostics are reshaping the global sleep apnea clinical market. Download Full PDF Sample Copy of Market Report @ https://exactitudeconsultancy.com/request-sample/73637 Market Overview The
Rhabdomyosarcoma (RMS) Clinical Market Strengthens as Pediatric Oncology Advances, Genomic Profiling & Targeted Therapies Gain Momentum
Rhabdomyosarcoma (RMS) Clinical Market Strengthens as Pediatric Oncology Advance …
Rhabdomyosarcoma (RMS)-a rare but aggressive pediatric soft-tissue cancer-is gaining renewed clinical attention as researchers push for better diagnostics, innovative treatment combinations, and targeted therapies. Advancements in precision oncology, supportive care, and early diagnosis are reshaping the global RMS clinical landscape. This press release highlights key market trends, epidemiological insights, therapeutic developments, segmentation analysis, and the evolving strategies improving outcomes for children and adolescents with RMS. Download Full PDF Sample Copy of

All 5 Releases


More Releases for Imaging

Mobile Gamma Cameras Market 2018 -- 2028 | By Indication Type (Cardiac Imaging, …
Mobile gamma camera is a portable version of the stationary gamma or angler camera used for nuclear imaging. Nuclear imaging involves injecting a radio nucleotide in the body or organ under study and record the resulting redioactivity by scanning with a gamma camera. Nuclear imaging is performed owing to its better resolution and selectivity than non-nuclear imaging such as MRI and ultrasound. The mobile gamma camera types include single, dual and
Holographic Imaging Market Latest Technological Innovations on Holoxica, Zebra I …
Market Study Report Adds Global Holographic Imaging Market Size, Status and Forecast 2024 added to its database. The report provides key statistics on the current state of the industry and other analytical data to understand the market. Emergence of 3D holographic imaging has revolutionized the medical imaging and surgery. The technology converts the given two dimensional MRI and CT scan imaging data into interactive virtual reality images. Using these images doctors
Holographic Imaging Market : Eminent Players – EON Reality, Holoxica, Zebra Im …
Holographic Imaging Market size is set to exceed USD 3 billion by 2024; according to a new research study published by Global Market Insights, Inc. Increasing adoption of holographic imaging in medical education should drive the holographic imaging market size over the forecast years. Medical practitioners and students are widely using holographic techniques to effectively study the human body, since the technology provides surgeons with a detailed view of patient
Holographic Imaging Market Eminent Players – EON Reality, Holoxica, Zebra Imag …
Holographic Imaging Market size is set to exceed USD 3 billion by 2024; according to a new research study published by Global Market Insights, Inc. Increasing adoption of holographic imaging in medical education should drive the holographic imaging market size over the forecast years. Medical practitioners and students are widely using holographic techniques to effectively study the human body, since the technology provides surgeons with a detailed view of patient anatomy
Holographic Imaging Market Projections Reviewed On Holoxica, Zebra Imaging, Oviz …
The newly released research at Market Study Report titled “2017-2024 Global Holographic Imaging Consumption Market Report” provides data, information, brief analysis, company profiles, statistics for past years and forecasts for next few years. Holographic Imaging Market size is set to exceed USD 3 billion by 2024. U.S. holographic imaging market accounted for significant industry share with expectations to witness healthy growth over coming years. Increasing biomedical research initiatives in holographic image
Digital Imaging Market,Digital Imaging Industry, Global Digital Imaging Market,D …
Latest industry research report on: Global Digital Imaging Market : Industry Size, Share, Research, Reviews, Analysis, Strategies, Demand, Growth, Segmentation, Parameters, Forecasts This report presents the worldwide Digital Imaging market size (value, production and consumption), splits the breakdown (data status 2013-2018 and forecast to 2025), by manufacturers, region, type and application. This study also analyzes the market status, market share, growth rate, future trends, market drivers, opportunities and challenges, risks and entry